Alpha-7 nicotinic receptor

From WikiMD's Medical Encyclopedia

Revision as of 11:34, 15 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Alpha-7 Nicotinic Receptor[edit]

Structure of the Alpha-7 Nicotinic Receptor

The Alpha-7 nicotinic receptor is a type of nicotinic acetylcholine receptor (nAChR) that is primarily found in the central nervous system. It is a ligand-gated ion channel that is activated by the neurotransmitter acetylcholine as well as by the alkaloid nicotine. The receptor is known for its high permeability to calcium ions (Ca2+), which distinguishes it from other types of nicotinic receptors.

Structure[edit]

The Alpha-7 nicotinic receptor is composed of five identical subunits, each of which spans the cell membrane and forms a central pore. This pentameric structure is typical of the Cys-loop receptor family, to which the nicotinic receptors belong. The receptor's structure allows it to undergo conformational changes upon binding to its ligands, leading to the opening of the ion channel.

Function[edit]

The primary function of the Alpha-7 nicotinic receptor is to mediate fast synaptic transmission in the nervous system. When activated, the receptor allows the influx of calcium ions, which can trigger various intracellular signaling pathways. This influx of calcium is crucial for processes such as neurotransmitter release, neuronal plasticity, and gene expression.

Distribution[edit]

Alpha-7 nicotinic receptors are widely distributed throughout the brain, with high concentrations in areas such as the hippocampus, cortex, and thalamus. They are also found in the peripheral nervous system and in non-neuronal tissues, including immune cells and epithelial cells.

Clinical Significance[edit]

The Alpha-7 nicotinic receptor has been implicated in various neurological and psychiatric disorders. It is a target of interest in the treatment of conditions such as schizophrenia, Alzheimer's disease, and inflammatory diseases. Agonists and modulators of the Alpha-7 receptor are being investigated for their potential therapeutic effects in these conditions.

Related Pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Alpha-7_nicotinic_receptor&oldid=6296345"